Streetbeat News

Assets

ME

23andMe is cutting 40% of its workforce and halting its therapy development projects to stabilize the business. The company is exploring options to license or sell these projects.

Portfolio Pulse from

November 12, 2024 | 9:30 am

PSKOF

Poland's largest refiner, Orlen, plans to invest $852.3 million to upgrade its energy distribution network, focusing on improving electricity delivery in northern and central Poland.

Portfolio Pulse from

November 12, 2024 | 9:15 am

BAM

SEGRO PLC will not enhance its all-share offer for Tritax Eurobox PLC but has agreed to purchase some assets from Brookfield Asset Management, which offered a higher cash deal for Eurobox.

Portfolio Pulse from

November 12, 2024 | 9:15 am

GEGYY

Genel Energy is focusing on optimizing cash flows, evolving its capital structure, and exploring new asset acquisitions, as stated by CEO Paul Weir in their Q3 update.

Portfolio Pulse from

November 12, 2024 | 8:45 am

AZN

AstraZeneca PLC has announced a $3.5 billion investment to expand its research and manufacturing operations in the US by 2026, creating over 1,000 high-skilled jobs. This is part of its 'Ambition 2030' plan to reach $80 billion in revenue by 2030.

Portfolio Pulse from

November 12, 2024 | 8:30 am

PAAS

Pan American Silver is rated 'Buy' with a 24-month horizon due to its attractive valuation and growth potential from rising precious metal prices. Strong fundamentals, including a $1.22 billion liquidity buffer and significant production growth catalysts, support this outlook.

Portfolio Pulse from

November 12, 2024 | 6:15 am

ULTY

YieldMax Ultra Option Income Strategy ETF (ULTY) offers a high distribution yield but has underperformed with only 2.4% total performance since inception. The fund's strategy involves selling options on volatile stocks, leading to high premiums but significant principal erosion. ULTY's approach contrasts with more conservative ETFs like JEPI and QYLD.

Portfolio Pulse from

November 12, 2024 | 5:45 am

SPYV

SPYV, an ETF replicating the S&P 500 Value Index, has been upgraded due to its appropriate valuation amid long-term risks. It focuses on large-cap value stocks, with financials making up 23.73% of the ETF. Despite potential risks from high market valuations and Fed policies, SPYV's lower valuation is seen as beneficial.

Portfolio Pulse from

November 12, 2024 | 1:30 am

ME

23andMe Holding Co. (Nasdaq: ME) announced a major business restructuring, reducing its workforce by 40% and discontinuing its therapeutics division. The company expects to save over $35 million annually.

Portfolio Pulse from

November 11, 2024 | 10:45 pm